Atlas Trials

Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis

Clinical trial NCT02148744 · COMPLETED

Trial details

NCT number
NCT02148744
Sponsor
Xencor, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Allergic RhinitisAllergic ConjunctivitisAtopic Dermatitis
Start date
2014-05-01
Primary completion
2015-09-21
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.